Stroock Represents AMETEK in Acquisition of MOCON
New York, NY, April 17, 2017 – Stroock represents AMETEK, Inc. (NYSE: AME) in its announced acquisition of laboratory analytics provider MOCON, Inc. (NASDAQ: MOCO). The all-cash deal has a value of approximately $182 million, in which AMETEK is acquiring MOCON’s outstanding shares for $30 per share. The transaction is expected to be completed in the late second quarter or third quarter of calendar year 2017.
Stroock’s deal team was led by corporate partners Todd Lenson and Jordan Rosenbaum, along with partners Ian DiBernardo (Intellectual Property), Marissa Holob (Employee Benefits and Executive Compensation), Howard Lavin (Employment) and Jeffrey Uffner (Tax); special counsels Elizabeth DiMichele and Jeffrey Mann; and associates Anthony Distinti, Brian Friederich, Belinda Gao, Yee Hong, Daniel Park and Nicholas Richard.
AMETEK is a leading global manufacturer of electronic instruments and electro-mechanical devices with annual sales of approximately $4.0 billion, and the common stock of AMETEK is a component of the S&P 500 Index. MOCON is a leading provider of laboratory and field gas analysis instrumentation to research laboratories, production facilities and quality control departments in food and beverage, pharmaceutical, and industrial applications.
Stroock has represented AMETEK in numerous strategic middle-market acquisitions, including its 2014 acquisition of Zygo Corporation (NASDAQ: ZIGO).
Stroock provides strategic transactional, regulatory and litigation advice to advance the business objectives of leading financial institutions, multinational corporations and entrepreneurial businesses in the U.S. and globally. Our award-winning corporate practice spans all areas of transactional and business matters including capital markets, mergers & acquisitions, tax, financial restructurings, corporate governance, executive compensation and employee benefits, intellectual property and business formation. For more, www.stroock.com.